Institutional Fund
Rhenman & Partners Asset Management Ab
Stockholm, SwedenCIK 15998825 filings on record
Portfolio Value
$810.49M
Q1 2026
Holdings
86
Reported positions
New Buys
11
Opened this quarter
QoQ Change
-24.3%
from $1.07B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Boston Scientific Corp4.8%
- Regeneron Pharmaceuticals4.6%
- Eli Lilly & Co3.8%
- Insmed Inc3.2%
- Cvs Health Corp3.0%
- Gilead Sciences Inc2.9%
- Other77.7%
Portfolio Holdings
86 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Boston Scientific Corp | 625.0K | $39.22M | 4.8% | +193.8K | Added |
| 2 | Regeneron Pharmaceuticals | 48.1K | $37.16M | 4.6% | −13.3K | Reduced |
| 3 | Eli Lilly & Co | 33.7K | $31.01M | 3.8% | −8.5K | Reduced |
| 4 | Insmed Inc | 159.8K | $26.12M | 3.2% | +46.2K | Added |
| 5 | Cvs Health Corp | 336.5K | $24.17M | 3.0% | +1.0K | Added |
| 6 | Gilead Sciences Inc | 167.8K | $23.38M | 2.9% | +41.6K | Added |
| 7 | Thermo Fisher Scientific Inc | 41.3K | $20.32M | 2.5% | +7.7K | Added |
| 8 | Biogen Inc | 109.1K | $20.00M | 2.5% | +16.8K | Added |
| 9 | Vertex Pharmaceuticals Inc | 43.5K | $19.42M | 2.4% | +9.2K | Added |
| 10 | Alignment Healthcare Inc | 1.05M | $18.56M | 2.3% | +44.0K | Added |
76 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio